Product Information
DAPTOMYCIN 350 MG VIAL is a generic product labeled by Sagent Pharmaceuticals, priced at $13.4180 per EA under NDC 25021017966. Its NADAC has been published 80 times since Dec 18, 2024.
Strength
350 mg/7mL
Manufacturer
Sagent PharmaceuticalsNDC
25021017966
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Last Updated
7/23/2025
Active Ingredients
DAPTOMYCINApproval Type
New Drug (NDA)
FDA Application
NDA208385On Market Since
1/15/2018
Pharmacological Classes
Price Statistics
The NADAC for DAPTOMYCIN 350 MG VIAL has been published 80 times since Dec 18, 2024, and over the history we have for it it has declined 25.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.4180 per EA |
|---|---|
| All-time high | $17.9420 (Apr 16, 2025) |
| All-time low | $13.3620 (Apr 23, 2025) |
| 52-week high | $13.4180 |
| 52-week low | $13.3900 |
| Median price | $13.4180 |
| Average price | $14.4299 |
| Largest weekly change | -25.5% (Apr 23, 2025) |
| Weeks tracked | 80 |
| Tracking since | Dec 18, 2024 |
Generic Alternatives
The matcher finds 7 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 7 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DAPTOMYCIN 350 MG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for DAPTOMYCIN 350 MG VIAL, manufactured by Sagent Pharmaceuticals, is $13.4180 per EA (NDC 25021017966), effective Jun 24, 2026.
How has the price of DAPTOMYCIN 350 MG VIAL changed over time?
Over the history we have for it, the NADAC for DAPTOMYCIN 350 MG VIAL has declined 25.2%. It has been tracked across 80 weekly CMS publications since Dec 18, 2024.
What are the highest and lowest recorded NADAC prices for DAPTOMYCIN 350 MG VIAL?
Since Dec 18, 2024, the NADAC for DAPTOMYCIN 350 MG VIAL has ranged from a low of $13.3620 (Apr 23, 2025) to a high of $17.9420 (Apr 16, 2025), with a median of $13.4180 per EA.
Are there cheaper alternatives to DAPTOMYCIN 350 MG VIAL?
7 NADAC-published products share the same active ingredient, strength, and dosage form as DAPTOMYCIN 350 MG VIAL, but none are currently priced below it.
Who manufactures DAPTOMYCIN 350 MG VIAL?
DAPTOMYCIN 350 MG VIAL (NDC 25021017966) is labeled by Sagent Pharmaceuticals, and CMS classifies it as a generic product.
Related Drugs
Same classification